1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH) (specifically NIEHS for Phase I applications under this NOFO). This NOFO invites eligible United States small business concerns (SBCs) to submit STTR Phase I and Fast-Track grant applications.
The program aims to support mission-driven scientists in transitioning scientific discoveries into healthcare solutions by addressing the need for entrepreneurial skills alongside technical expertise.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Eligible United States small business concerns (SBCs). Confirm the full requirements in the official notice before applying.
The current listing shows phase I budgets for general applications are limited to $306,872 total cost (direct costs, indirect costs, and fees). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed) is funded by National Institutes of Health (NIH) (specifically NIEHS for Phase I applications under this NOFO). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NIH consolidated more than 300 Notices of Funding Opportunity off the books in 2025 and is pushing investigators toward parent announcements in FY2026. The framing is administrative simplification. The mechanism is a structural shift in which research areas get advertised and which do not — and which investigators get rewarded for ignoring NOFO topics entirely.
Read articlePAR-27-054 and PAR-27-055 replace COBRE's Phase 1-2-3 model with two tracks: a 15-year Development-Expansion-Sustainability path and a 10-year Expansion-Sustainability path. At $1.5 million per year in direct costs across 23 states and Puerto Rico, with new research cores prohibited in the final phase and eligibility capped at three active awards per institution, the track you claim is the most consequential choice in the application.
Read articleThe Health and Extreme Weather highlighted topic went live September 1, 2026 with eleven awarding institutes and expires May 1, 2028. There is no set-aside, no separate deadline, and no review criteria — which makes the institute-by-institute language the only real signal, and it is not uniform.
Read article